The oxidative and catabolic metabolic profile of AF+ microglia along with their overrepresentation of autophagic proteins points to an impaired activation of mTOR in AF+ microglia and suggests that pharmacological modulation of mTOR may restore AF+ microglia physiology, a hypothesis that remains to be tested. The gene discussed is MTOR; the disease is atrial fibrillation.